All jobs lost as Scottish cancer therapy firm in liquidation
TC BioPharm was the only Scottish life sciences company on the US Nasdaq exchange when it launched there in 2022 but was delisted last year. Administrators were announced in October and now, after a buyer could not be found, liquidators have been appointed. All 14 staff were made redundant. The plan had been to create…

